Your browser doesn't support javascript.
loading
Targeting VEGFR-2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies.
Alsaif, Nawaf A; Mahdy, Hazem A; Alanazi, Mohammed M; Obaidullah, Ahmad J; Alkahtani, Hamad M; Al-Hossaini, Abdullah M; Al-Mehizi, Abdulrahman A; Elwan, Alaa; Taghour, Mohammed S.
Afiliación
  • Alsaif NA; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Mahdy HA; Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr, Egypt.
  • Alanazi MM; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Obaidullah AJ; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Alkahtani HM; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Al-Hossaini AM; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Al-Mehizi AA; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Elwan A; Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr, Egypt.
  • Taghour MS; Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr, Egypt.
Arch Pharm (Weinheim) ; 355(2): e2100359, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34862634

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinoxalinas / Triazoles / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Arch Pharm (Weinheim) Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quinoxalinas / Triazoles / Receptor 2 de Factores de Crecimiento Endotelial Vascular / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Arch Pharm (Weinheim) Año: 2022 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Alemania